fewer orders for Onglyza, Nesina, and other "gliptins" for treating type 2 diabetes
You might see fewer orders for Onglyza, Nesina, and other "gliptins" for treating type 2 diabetes.
Gliptins are popular because they're taken orally once a day...and rarely cause hypoglycemia or weight gain.
But they don't improve diabetes numbers that much...and there are concerns about possible pancreatitis and heart failure.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote